Yinlong Zhang
Papers
1
Total Citations
1,480
H-Index
1
About
Yinlong Zhang is a pioneering biomedical engineer and nanomedicine researcher whose work sits at the exciting intersection of DNA nanotechnology and cancer therapeutics. His most celebrated contribution is the development of a programmable DNA nanorobot capable of functioning as an intelligent cancer therapeutic *in vivo*, a landmark 2018 study that has garnered over 1,480 citations and captured international scientific attention. This work demonstrated that DNA nanostructures could be engineered to remain inert until encountering a specific molecular trigger — such as a tumor-associated protein — at which point they activate to deliver a targeted therapeutic payload directly to cancer cells. The elegance of this approach lies in its precision: by exploiting the programmability of DNA base-pairing, Zhang and colleagues created a system that minimizes off-target effects while maximizing therapeutic efficacy. This breakthrough helped establish DNA nanorobots as a serious frontier in next-generation drug delivery and cancer immunotherapy. Zhang's research has significantly advanced the field of smart nanomedicine, inspiring a growing wave of scientists to explore biologically responsive nanostructures as viable clinical tools.
Research Focus
Key Achievements
Top Papers
- 1